ctDNA Testing May Better Predict Breast Cancer Recurrence Than Current Standard
A study reports that post-treatment circulating tumor DNA levels may better predict recurrence in HER2-positive breast cancer patients than current pCR measures.
Category: Breast
Breast
Latest
Breast
Latest
A Precision Oncology Approach Calls for Regular ESR1 Monitoring
Emerging liquid biopsy techniques enable sensitive, routine monitoring of ESR1 mutations in metastatic HR+ breast cancer.
Breast
Latest
HER2-ultralow Metastatic Breast Cancer Companion Diagnostic Approved by FDA
Roche's PATHWAY anti-HER2/neu (4B5) test has received FDA approval to ID patients with HR-positive, HER2-ultralow metastatic breast cancer.
New Blood Test Predicts Breast Cancer Recurrence Before Relapse
A new blood test can predict the recurrence of breast cancer in high-risk patients by detecting cancer DNA months or years before relapse.
Read More
PreciseDx Announces Poster Presentation for Breast Cancer Recurrence Test
PreciseDx will present findings on their AI-driven breast cancer recurrence prediction test at the 2024 ASCO Annual Meeting.
Read More
UCLA and PreciseDx Collaborate on AI-Powered Breast Cancer Recurrence Diagnostics
This collaborative study seeks to represent a significant step forward in digital pathology and oncology breast cancer research
Read More
Bio-Rad Launches Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection
Bio-Rad Laboratories launched its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit.Â
Read More
The Breast Cancer Index Test is Guiding Hormone Therapy Decisions
BCI testing is reshaping treatment decisions for early-stage HR+ breast cancer patients by helping guide endocrine therapy choices.
Read More
New Test Predicts Recurrence Rate in Early-Stage Invasive Breast Cancer Patients
The AidaBreast novel biosignature also predicts radiation therapy benefit for early-stage invasive breast cancer patients.
Read More
Why ESR1 Mutation Monitoring Can Keep One Step Ahead of Breast Cancer
For patients with metastatic HR+ breast cancer, there may be no test more important than monitoring for an ESR1 mutation.
Read More
Detecting Breast Cancer through a Spit Test
Scientists developed a saliva test that screens for breast cancer, which is showing promising results in experimental testing.
Read More
Breast Cancer Test May Make Bad Chemo Recommendations for Black Patients
The commonly ordered biomarker test is used to guide doctor’s recommendations for patients with estrogen receptor-positive breast cancer.
Read More
Weill Cornell Medicine Gets Grant for Breast Cancer Liquid Biopsy
A new test uses AI to see whether a patient is positive for cancer as soon as detectable by mammogram or earlier, and before symptoms arise.
Read More
Male Breast Cancer Diagnosis Leads to New Treatment Approach
Though breast cancer rates for men are much lower, it is estimated that in 2023, about 2,800 men will be diagnosed with breast cancer.
Read More
Exai Bio’s RNA-Based Liquid Biopsy Platform Detects Early Stage Breast Cancer Accurately
Exai Bio’s liquid biopsy platform can detect breast cancer at the earliest stages and the smallest tumor sizes using a standard blood sample.Â
Read More
Reveal Genomics Details Success of Liquid Biopsy Test for Metastatic Breast Cancer
DNADX utilizes sequencing DNA data from tumor tissue or plasma circulating tumor DNA to classify breast cancer into four subtypes or clusters.
Read More
Digital Morphology Solution Predicts Breast Cancer Recurrence
PreciseBreast, an AI-powered digital morphology tool, has a fast turnaround time and is cost-effective compared to gene expression tests.
Read More
Universal Hereditary Cancer Genetic Testing Breast Cancer Improves Patient Outcomes
Invitae announced the results of its study on universal hereditary cancer genetic testing in breast cancer patients in a rural population.
Read More